Compare BRN & ALUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | BRN | ALUR |
|---|---|---|
| Founded | 1956 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | |
| Sector | Energy | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.7M | 13.3M |
| IPO Year | 1995 | N/A |
| Metric | BRN | ALUR |
|---|---|---|
| Price | $1.03 | $1.12 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $9.25 |
| AVG Volume (30 Days) | ★ 155.7K | 76.4K |
| Earning Date | 04-02-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,697,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $15.54 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.92 | $0.95 |
| 52 Week High | $2.28 | $4.18 |
| Indicator | BRN | ALUR |
|---|---|---|
| Relative Strength Index (RSI) | 57.91 | 40.69 |
| Support Level | $0.98 | $1.05 |
| Resistance Level | $1.06 | $1.41 |
| Average True Range (ATR) | 0.07 | 0.14 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 100.00 | 37.14 |
Barnwell Industries Inc is an oil and gas company engaged in the acquisition, development, production, and sale of crude oil and natural gas. The Company operates through two segments: the Oil and Natural Gas segment, which focuses on oil and natural gas development, production, acquisitions, and sales in the United States and Canada; and the Land Investment segment, which owns leasehold land interests in Hawaii. The Company generates the majority of its revenue from the Oil and Natural Gas segment. The company operates in two geographic regions, the United States and Canada, with Canada contributing the majority of revenue.
Allurion Technologies Inc is a medical device company that focuses on creating a weight loss platform to treat overweight patients. Its platform, the Allurion Program, features the world's first and only swallowable, procedure-less intragastric balloon for weight loss and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion VCS. Its proprietary intragastric balloon, the Allurion Balloon, is in the form of a swallowed capsule that is administered to patients under the guidance of a healthcare provider without surgery, endoscopy, or anesthesia.